India

India opens up immunization to more people, vaccine exports to dwindle

Reuters

This is AI generated summarization, which may have errors. For context, always refer to the full article.

India opens up immunization to more people, vaccine exports to dwindle

VACCINATIONS. A woman watches as a healthcare worker fills a syringe with a dose of COVISHIELD, the coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, at Max Super Speciality Hospital, in New Delhi, India on March 17, 2021.

File photo by Adnan Abidi/Reuters

India has so far injected 64 million doses and exported nearly as many, prompting criticism in the country

India opened up its coronavirus inoculation program to people above 45 on Thursday, April 1, as infections surge, which will delay vaccine exports from the world’s biggest maker of the drug.

The country, with the most number of reported COVID-19 cases after the United States and Brazil, has so far injected 64 million doses and exported nearly as many. This has raised criticism at home as India’s per-capita vaccination figure is much lower than many countries.

The government has previously said that people over 45 can register for inoculation from April 1.

India initially focused on front-like workers, the elderly and those suffering from other health conditions, unlike some richer countries that have made all their adults eligible to get inoculated.

New Delhi says it is working towards that goal, and Health Minister Harsh Vardhan tweeted that there would be no vaccine shortage in the country as it opens up the vaccination program.

“Centre to continually replenish states’ supplies,” he said on Twitter. “Avoid overstocking and under stocking.”

India has already decided to delay big vaccine exports for now, including to the WHO-backed global vaccine alliance COVAX.

Must Read

Asian countries seek vaccine supplies after India export curbs hit COVAX

Asian countries seek vaccine supplies after India export curbs hit COVAX

It is currently using the AstraZeneca vaccine and a shot developed at home by Bharat Biotech, which is struggling to step up supplies. India’s drug regulator is soon expected to approve Russia’s Sputnik V vaccine.

India has reported more than 12 million infections, including a big surge last month. Deaths stand at more than 162,400. – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!